GlassScriptPhysician profile
Clare T Williams
NPI 1932146271
$16,309.74
in general payments reported to CMS, 2019-2025
58 companies · $2,383 in 2025
The $2,383 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,398 · 2020: $1,454 · 2021: $2,935 · 2022: $2,014 · 2023: $2,464 · 2024: $2,661 · 2025: $2,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,509.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,538.37 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,472.47 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $1,291.00 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,267.81 | 2019-2025 | Trelegy Ellipta, Bexsero, Shingrix |
| Amgen INC. | $1,254.64 | 2019-2025 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $988.39 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $639.08 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $598.79 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $551.73 | 2019-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Amarin Pharma, INC. | $550.27 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $493.13 | 2019-2024 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $415.57 | 2019-2023 | Tradjenta, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $409.00 | 2021-2025 | |
| Mylan Specialty L.P. | $390.82 | 2019-2024 | Yupelri |
| Dexcom, INC. | $348.07 | 2021-2025 | Dexcom G6 Transmitter |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $342.68 | 2024-2025 | Auvelity |
| Braeburn INC. | $287.41 | 2023-2025 | Brixadi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $267.67 | 2019-2025 | Xifaxan |
| Biohaven Pharmaceuticals, INC. | $266.74 | 2021 | |
| Indivior INC. | $264.95 | 2021-2025 | Sublocade |
| Otsuka America Pharmaceutical, INC. | $208.88 | 2023-2025 | Rexulti, Abilify Maintena |
| Electromed, INC. | $168.21 | 2022-2025 | Smartvest |
| Biohaven Pharmaceutical Holding Company LTD. | $166.32 | 2022 | |
| Lundbeck LLC | $158.18 | 2022-2025 | Vyepti, Rexulti |
| Sunovion Pharmaceuticals INC. | $153.33 | 2021-2022 | |
| Abbott Laboratories | $148.15 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Sumitomo Pharma America, INC. | $135.39 | 2023-2025 | Gemtesa |
| Edwards Lifesciences Corporation | $130.44 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $118.34 | 2019-2024 | Eliquis |
| Sanofi-Aventis U.S. LLC | $94.35 | 2019-2021 | |
| Astellas Pharma US INC | $90.10 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $82.31 | 2020-2021 | |
| Viiv Healthcare Company | $81.67 | 2025 | Apretude |
| Insulet Corporation | $74.66 | 2023-2025 | Omnipod |
| Grifols USA, LLC | $71.00 | 2019-2025 | Prolastin-C Liquid |
| Exact Sciences Corporation | $65.15 | 2023-2024 | Cologuard Collection Kit |
| Viatris Specialty LLC | $64.03 | 2025 | Yupelri |
| Allergan, INC. | $60.57 | 2020 | |
| Seqirus USA INC | $58.46 | 2024-2025 | Flucelvax, Fluad |
| Boston Scientific Corporation | $58.46 | 2025 | Watchman Access System |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $57.35 | 2024-2025 | Caplyta |
| Xeris Pharmaceuticals, INC. | $53.51 | 2022-2023 | Gvoke Hypopen |
| Teva Pharmaceuticals USA, INC. | $47.78 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $42.32 | 2019-2020 | |
| Organon LLC | $30.13 | 2024-2025 | Nexplanon |
| Genzyme Corporation | $28.72 | 2025 | |
| Exeltis, USA INC. | $28.48 | 2022 | |
| Uswm, LLC | $26.55 | 2022 | |
| Esperion Therapeutics, INC. | $25.17 | 2021 | |
| Impel Pharmaceuticals INC. | $19.89 | 2023 | Trudhesa |
| Optos, INC. | $17.86 | 2021 | |
| Vanda Pharmaceuticals INC. | $17.42 | 2025 | Fanapt |
| Eisai INC. | $16.21 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $16.08 | 2025 | Imcivree |
| Sanofi Pasteur INC. | $15.02 | 2023 | |
| Arbor Pharmaceuticals, INC. | $13.89 | 2019 | |
| Gilead Sciences, INC. | $13.70 | 2019 | |
| Philips North America LLC | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clare Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.